Arbutus Biopharma

ABUS

Market cap $781M

77 hedge funds and large institutions have $616M invested in Arbutus Biopharma in 2015 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 18 closing their positions.

Upgrade to unlock

New

Increased

Maintained

Reduced

Closed

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

57% more funds holding

Funds holding: 49 → 77 (+28)

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

$10.3M

Puts

$3.78M

Net Calls

Net Calls Change

Top Buyers

1		+$280M
2		+$47.4M
3		+$38.8M
4	BRC Blue Ridge Capital New York	+$29.7M
5	D.E. Shaw & Co New York	+$28.4M

Top Sellers

1		-$5.3M
2		-$1.89M
3		-$1.44M
4	NCCM Nine Chapters Capital Management Short Hills, New Jersey	-$1.11M
5	IGIM I.G. Investment Management Winnipeg, Manitoba, Canada	-$976K

#	Name	Holding
76	76	$1K
77	77	–
78	78	–
79	79	–
80	80	–
81	81	–
82	82	–
83	83	–
84	84	–
85	85	–
86	86	–
87	87	–
88	88	–
89	89	–
90	90	–
91	91	–
92	92	–
93	93	–
94	94	–

#	Name	Holding
76	76	$1K
77	77	–
78	78	–
79	79	–
80	80	–
81	81	–
82	82	–
83	83	–
84	84	–
85	85	–
86	86	–
87	87	–
88	88	–
89	89	–
90	90	–
91	91	–
92	92	–
93	93	–
94	94	–

#	Name	Holding
76	76	$1K
77	77	–
78	78	–
79	79	–
80	80	–
81	81	–
82	82	–
83	83	–
84	84	–
85	85	–
86	86	–
87	87	–
88	88	–
89	89	–
90	90	–
91	91	–
92	92	–
93	93	–
94	94	–

Arbutus Biopharma ABUS Market cap $781M